Sun Pharma Slumps Over 10% as Daiichi Exits
Japan's Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion in Sun Pharmaceutical Industries.21-04-2015
21-04-2015
Daiichi's $3.6-bn exit from Sun Pharma hits rupee, stocks
Daiichi's $3.6-bn exit from Sun Pharma hits rupee, stocks The partially convertible rupee pared some of its earlier losses to trade at 62.85/86 after earlier falling to 63.1550 per dollar.21-04-2015
Daiichi Sankyo to sell stake in Sun Pharma
Japanese drug maker Daiichi Sankyo will sell part or all of its holding in Sun Pharmaceutical Industries which it received following the merger of Ranbaxy into the Indian pharma major.20-04-2015
Japan's Daiichi Sankyo To Sell Up To $3.6 Billion Sun Pharma Stake: Report
The Japanese company is selling its 8.9 per cent stake in Sun Pharma, India's largest drugmaker by sales, via block deals on the Indian exchanges, said the person, who declined to be named as he was n...20-04-2015
Sun Pharma up on reports Shanghvi may pick stake from Daiichi
Sun Pharma rose as much as 2.8 per cent to hit its intraday high of Rs 1066.40 on the BSE, after ET NOW reported the story.20-04-2015
Six Sensex cos add Rs 53,284.6 cr to market cap; Sun Pharma shines
The combined market valuation of six of the top 10 Sensex companies rose Rs 53,284.6 crore in the week gone by, with Sun Pharma and ONGC emerging as the biggest gainers.While RIL, ONGC, ITC...19-04-2015
Sun Pharma dips on listing of new shares
A 335 million equity shares issued pursuant to the scheme of amalgamation of Ranbaxy are listed w.e.f. April 17, 2015.17-04-2015
Sun Pharma, Israel varsity tie up for cancer research
Sun Pharmaceutical Industries and the TechnionIsrael institute of technology have entered into an exclusive worldwide research and licence agreement for the development of novel anti-cance...16-04-2015
Sun Pharma, Israel University Ink Pact to Develop Anti-Cancer Drugs
Sun Pharmaceutical Industries has inked a pact with Israel's Technion University to develop anti-cancer drugs.16-04-2015